Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Rivian Falls, Fiserv Rises, Crinetics Pharmaceuticals Gains on Vertex Deal | Stock Movers
Posted
July 7, 2026
Views
195
Likes
3
Engagement
1.54%
July 7, 2026
195
3
1.54%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:48Now PlayingOn this episode of Stock Movers:
- Rivian (RIVN) tumbled after the electric vehicle maker said it will sell 75 million shares to fund equity contributions related to a US Department of Energy loan. The offering would raise about $1.5 billion at the closing price of $20.14 per share, with Goldman Sachs Group Inc. leading the share sale.
- Fiserv (FISV) shares gain after the Wall Street Journal reported that big Wall Street banks have held preliminary discussions about a deal to acquire a debit network owned by the financial-technology company. JPMorgan Chase, Bank of America, Wells Fargo and PNC Financial Services Group were the banks involved in the discussions, according to the WSJ.
- Crinetics Pharmaceuticals (CRNX) shares rise. Crinetics Pharmaceuticals Inc. agreed to buy Crinetics Pharmaceuticals Inc. for $10 billion in cash to expand into endocrinology. The deal values Crinetics at $8.8 billion net of cash acquired and will boost Vertex’s adjusted operating income in 2029.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Rivian Falls, Fiserv Rises, Crinetics Pharmaceuticals Gains on Vertex Deal
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
